Sakata Inx Corp

Sakata Inx Corp maintains a conservative capital structure with a debt-to-equity ratio of 0.28, well below the typical leverage for specialty chemicals firms. The company holds 20.6 billion JPY in cash and equivalents, but net cash is negative after subtracting total debt of 33.6 billion JPY. With a current ratio of 2.04, the firm demonstrates strong short-term liquidity, though its liquidity risk is assessed as medium due to the net cash position. Profitability metrics show a return on equity of 9.74% and return on assets of 5.14%, both below the industry median for specialty chemicals. The company's operating margin of 5.45% (14.03 billion JPY operating income on 257.67 billion JPY revenue) lags behind the sector average, indicating potential pricing pressures or cost inefficiencies. Net income of 11.61 billion JPY represents a 4.5% margin, further underscoring the need for operational improvements. The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification in the provided data. This lack of segment and geographic diversification increases exposure to sector-specific risks and regional economic fluctuations. Looking ahead, the company is projected to maintain stable revenue with no significant growth expected in the next fiscal year. Capital expenditures of 8.14 billion JPY suggest ongoing investment in operations, but the free cash flow of 6.85 billion JPY indicates the company can fund operations without external financing. The dilution risk is assessed as low, with no near-term pressure from share issuance or convertible debt. The risk assessment highlights liquidity as the primary concern, with the company's net cash position being negative after accounting for total debt. No significant regulatory or geopolitical risks are explicitly mentioned in the provided data, though the specialty chemicals industry is subject to environmental regulations and raw material price volatility. Recent filings and transcripts do not show any material events affecting the company's operations or financial position in the last quarter. Analysts maintain a neutral stance with a mean recommendation of 2.0 (hold), and price targets ranging from 2,650 JPY to 3,100 JPY, with a mean of 2,875 JPY.